SCHEMBL23218752

SCHEMBL23218752

CCOC(=O)Cc1ccccc1OCc1nn(C(C)C)c2ccc(-c3cccc(N)c3)cc12

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CFD P00746 8/20 0.49
TBXAS1 P24557 1/20 0.39
TPSB2 P20231 6/20 0.38
F11 P03951 5/20 0.38
ICMT O60725 4/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
DHFR P00374 2/20 0.36
PLG P00747 1/20 0.36
PLAU P00749 1/20 0.36
KLKB1 P03952 1/20 0.36
F7 P08709 1/20 0.36
ELANE P08246 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CSNK1D P48730 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29852706 1.00 CFD (0.49) CFDTBXAS1TPSB2F11ICMT
SCHEMBL23219007 0.93 CFD (0.47) CFDTBXAS1TPSB2F11ICMT
SCHEMBL29852422 0.93 CFD (0.47) CFDTBXAS1TPSB2F11ICMT
SCHEMBL29122273 0.92 CFD (0.46) CFDTBXAS1TPSB2F11ICMT
SCHEMBL23219243 0.90 CFD (0.62) CFDTBXAS1TPSB2F11ICMT
SCHEMBL23229271 0.90 CFD (0.51) CFDTBXAS1TPSB2F11ICMT
SCHEMBL29852710 0.90 CFD (0.51) CFDTBXAS1TPSB2F11ICMT
SCHEMBL29852728 0.90 CFD (0.51) CFDTBXAS1TPSB2F11ICMT
SCHEMBL29853182 0.90 CFD (0.62) CFDTBXAS1TPSB2F11ICMT
SCHEMBL23219207 0.90 CFD (0.55) CFDTBXAS1TPSB2F11ICMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4041238-A1 ORAL COMPLEMENT FACTOR D INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2022-08-17 EP disclosed
CN-114502168-A Oral complement factor D inhibitors 拜奥克里斯特制药公司 2022-05-13 CN disclosed
WO-2021072198-A1 ORAL COMPLEMENT FACTOR D INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2021-04-15 WO disclosed